Future prospects for the chemotherapy of human trypanosomiasis
- 1 September 1990
- journal article
- review article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 84 (5) , 618-621
- https://doi.org/10.1016/0035-9203(90)90125-x
Abstract
Transient risk factors may play an important role in the aetiology of acute diarrhoea. These factors have not been well elucidated. To assess them, we monitored 479 children below the age of 5 years living in a well-defined urban community in Port Moresby, Papua New Guinea, for one year, using the nested case-control method with density sampling. Comparing the odds ratios, we found that eating food that had been kept for more than 12 h, eating away from home, temporary absence of mother from home for more than one day, and the presence of respiratory infection in the child, were statistically associated with an increased risk of diarrhoea. We conclude that these transient factors must be addressed if effective control of diarrhoea is to be achieved. We believe that further studies will identify the factors more precisely and provide a better understanding of the method we have employed.Keywords
This publication has 16 references indexed in Scilit:
- Novel biochemical pathways in parasitic protozoaParasitology, 1989
- Trypanothione metabolism: a chemotherapeutic target in trypanosomatidsParasitology Today, 1987
- Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasisAntimicrobial Agents and Chemotherapy, 1987
- Clinical and Pathological Aspects of Human African Trypanosomiasis (T. B. Gambiense) with Particular Reference to Reactive Arsenical EncephalopathyThe American Journal of Tropical Medicine and Hygiene, 1986
- α-Difluoromethylornithine induces protective immunity in mice inoculated with Plasmodium berghei sporozoitesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- HUMAN AFRICAN TRYPANOSOMIASIS (T.b. GAMBIENSE): A STUDY OF 16 FATAL CASES OF SLEEPING SICKNESS WITH SOME OBSERVATIONS ON ACUTE REACTIVE ARSENICAL ENCEPHALOPATHYNeuropathology and Applied Neurobiology, 1986
- New Drug Combination for Experimental Late-Stage African Trypanosomiasis: DL-α-Difluoromethylornithine (DFMO) with SuraminThe American Journal of Tropical Medicine and Hygiene, 1984
- The use of the 2 substituted 5-nitroimidazole, fexinidazole (Hoe 239) in the treatment of chronicT. brucei infections in miceZeitschrift Fur Parasitenkunde-Parasitology Research, 1983
- The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapyParasitology, 1977
- MSb and MSbB in the Treatment of Sleeping Sickness due to Infection withTrypanosoma GambiensePathogens and Global Health, 1953